119 related articles for article (PubMed ID: 1926270)
21. Metabolic kinetics of pseudoracemic propranolol in human liver microsomes. Enantioselectivity and quinidine inhibition.
Marathe PH; Shen DD; Nelson WL
Drug Metab Dispos; 1994; 22(2):237-47. PubMed ID: 8013280
[TBL] [Abstract][Full Text] [Related]
22. Regioselectivity and substrate concentration-dependency of involvement of the CYP2D subfamily in oxidative metabolism of amitriptyline and nortriptyline in rat liver microsomes.
Masubuchi Y; Iwasa T; Fujita S; Suzuki T; Horie T; Narimatsu S
J Pharm Pharmacol; 1996 Sep; 48(9):925-9. PubMed ID: 9036183
[TBL] [Abstract][Full Text] [Related]
23. Alprazolam does not inhibit the metabolism of nortriptyline in depressed patients or inhibit the metabolism of desipramine in human liver microsomes.
Bertilsson L; Aberg-Wistedt A; Lidén A; Otani K; Spina E
Ther Drug Monit; 1988; 10(2):231-3. PubMed ID: 3381243
[TBL] [Abstract][Full Text] [Related]
24. Clinical and biochemical effects during treatment of depression with nortriptyline: the role of 10-hydroxynortriptyline.
Nordin C; Bertilsson L; Siwers B
Clin Pharmacol Ther; 1987 Jul; 42(1):10-9. PubMed ID: 2439250
[TBL] [Abstract][Full Text] [Related]
25. In vitro assessment of competitive and time-dependent inhibition of the nevirapine metabolism by nortriptyline in rats.
Usach I; Ferrer JM; Peris JE
Biochem Pharmacol; 2018 Aug; 154():1-9. PubMed ID: 29674001
[TBL] [Abstract][Full Text] [Related]
26. Hydroxylation and demethylation of the tricyclic antidepressant nortriptyline by cDNA-expressed human cytochrome P-450 isozymes.
Olesen OV; Linnet K
Drug Metab Dispos; 1997 Jun; 25(6):740-4. PubMed ID: 9193876
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of desmethylimipramine 2-hydroxylation by drugs in human liver microsomes.
von Bahr C; Spina E; Birgersson C; Ericsson O; Göransson M; Henthorn T; Sjöqvist F
Biochem Pharmacol; 1985 Jul; 34(14):2501-5. PubMed ID: 4015690
[TBL] [Abstract][Full Text] [Related]
28. Demethylation and hydroxylation of amitriptyline, nortriptyline, and 10-hydroxyamitriptyline in human liver microsomes.
Mellström B; von Bahr C
Drug Metab Dispos; 1981; 9(6):565-8. PubMed ID: 6120818
[TBL] [Abstract][Full Text] [Related]
29. In vitro metabolism of quinidine: the (3S)-3-hydroxylation of quinidine is a specific marker reaction for cytochrome P-4503A4 activity in human liver microsomes.
Nielsen TL; Rasmussen BB; Flinois JP; Beaune P; Brosen K
J Pharmacol Exp Ther; 1999 Apr; 289(1):31-7. PubMed ID: 10086984
[TBL] [Abstract][Full Text] [Related]
30. Stereoselectivity in bunitrolol 4-hydroxylation in liver microsomes from marmosets and Japanese monkeys.
Narimatsu S; Gotoh M; Masubuchi Y; Horie T; Ohmori S; Kitada M; Kageyama T; Asaoka K; Yamamoto I; Suzuki T
Biol Pharm Bull; 1996 Nov; 19(11):1429-33. PubMed ID: 8951158
[TBL] [Abstract][Full Text] [Related]
31. Isomers of 10-hydroxynortriptyline in geriatric depression.
Young RC; Dhar AK; Kutt H; Alexopoulos GS
Ther Drug Monit; 1988; 10(2):164-7. PubMed ID: 3381232
[TBL] [Abstract][Full Text] [Related]
32. Metabolism of amitriptyline with CYP2D6 expressed in a human cell line.
Coutts RT; Bach MV; Baker GB
Xenobiotica; 1997 Jan; 27(1):33-47. PubMed ID: 9041677
[TBL] [Abstract][Full Text] [Related]
33. Propranolol oxidation by human liver microsomes--the use of cumene hydroperoxide to probe isoenzyme specificity and regio- and stereoselectivity.
Otton SV; Gillam EM; Lennard MS; Tucker GT; Woods HF
Br J Clin Pharmacol; 1990 Nov; 30(5):751-60. PubMed ID: 2271375
[TBL] [Abstract][Full Text] [Related]
34. Studies on active transport of (E)-10-hydroxynortriptyline in the kidney and brain of rats: effects of propranolol and quinidine.
Otani K; Kaneko S; Bertilsson L
Pharmacol Toxicol; 1991 May; 68(5):380-3. PubMed ID: 1946183
[TBL] [Abstract][Full Text] [Related]
35. Metabolism of prazepam by rat liver microsomes: stereoselective formation and N-dealkylation of 3-hydroxyprazepam.
Lu XL; Yang SK
Mol Pharmacol; 1989 Dec; 36(6):932-8. PubMed ID: 2601688
[TBL] [Abstract][Full Text] [Related]
36. Development of a high-performance liquid chromatographic method for the analysis of enatiomer/enantiomer interaction in oxidative metabolism of bunitrolol in rat liver microsomes.
Narimatsu S; Huang Y; Mizukami T; Masubuchi Y; Suzuki T
Anal Biochem; 1994 Oct; 222(1):256-61. PubMed ID: 7856858
[TBL] [Abstract][Full Text] [Related]
37. Steady-state plasma levels of E- and Z-10-OH-nortriptyline in nortriptyline-treated patients: significance of concurrent medication and the sparteine oxidation phenotype.
Gram LF; Brøsen K; Kragh-Sørensen P; Christensen P
Ther Drug Monit; 1989 Sep; 11(5):508-14. PubMed ID: 2815225
[TBL] [Abstract][Full Text] [Related]
38. Role of P450IID6, the target of the sparteine-debrisoquin oxidation polymorphism, in the metabolism of imipramine.
Brøsen K; Zeugin T; Meyer UA
Clin Pharmacol Ther; 1991 Jun; 49(6):609-17. PubMed ID: 2060250
[TBL] [Abstract][Full Text] [Related]
39. Plasma concentrations of nortriptyline and its 10-hydroxy metabolite in depressed patients--relationship to the debrisoquine hydroxylation metabolic ratio.
Nordin C; Siwers B; Benitez J; Bertilsson L
Br J Clin Pharmacol; 1985 Jun; 19(6):832-5. PubMed ID: 4027124
[TBL] [Abstract][Full Text] [Related]
40. Affinity of nortriptyline and its E-10-hydroxy metabolite for muscarinic receptors.
Nilvebrant L; Nordin C
Pharmacol Toxicol; 1991 Jan; 68(1):64-7. PubMed ID: 2008414
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
